Becton, Dickinson and Co (XSWX:BDX)
CHF 243.41 0 (0%) Market Cap: 63.44 Bil Enterprise Value: 78.37 Bil PE Ratio: 37.37 PB Ratio: 2.48 GF Score: 85/100

Becton Dickinson and Co at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 12:00PM GMT
Release Date Price: CHF237.26
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us for day 3 of the 2021 Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analysts here. And it's my pleasure to have Simon Campion, EVP and President of the Interventional segment at Becton Dickinson here with us today.

So before we jump into it, just a couple of housekeeping items. Just for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales rep. I'm going to open it to Kristen Stewart just to read some opening disclosure statements on their end, and Kris can take it away, please.

Kristen Marie Stewart
Becton, Dickinson and Company - SVP of Strategy & IR

Thanks, everyone, for joining us. Just a reminder, during today's discussion, we may be making some forward-looking statements, and it is possible that actual results could differ from our expectations.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot